Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$40.25 - $52.99 $13,081 - $17,221
-325 Reduced 2.59%
12,225 $507,000
Q1 2024

May 10, 2024

BUY
$47.98 - $54.4 $286,104 - $324,387
5,963 Added 90.53%
12,550 $680,000
Q4 2023

Jan 30, 2024

SELL
$48.48 - $57.85 $303,387 - $362,025
-6,258 Reduced 48.72%
6,587 $337,000
Q3 2023

Nov 15, 2023

SELL
$57.89 - $64.73 $9,378 - $10,486
-162 Reduced 1.25%
12,845 $745,000
Q2 2023

Aug 10, 2023

SELL
$63.71 - $70.74 $22,107 - $24,546
-347 Reduced 2.6%
13,007 $831,000
Q1 2023

Apr 28, 2023

BUY
$65.71 - $74.53 $1,182 - $1,341
18 Added 0.13%
13,354 $925,000
Q4 2022

Jan 25, 2023

SELL
$68.48 - $81.09 $23,968 - $28,381
-350 Reduced 2.56%
13,336 $0
Q3 2022

Nov 14, 2022

BUY
$0.13 - $76.84 $18 - $10,757
140 Added 1.03%
13,686 $973,000
Q2 2022

Jul 12, 2022

SELL
$72.62 - $79.98 $41,756 - $45,988
-575 Reduced 4.07%
13,546 $1.04 Million
Q1 2022

May 16, 2022

SELL
$61.48 - $73.72 $34,859 - $41,799
-567 Reduced 3.86%
14,121 $1.03 Million
Q4 2021

Feb 08, 2022

BUY
$53.63 - $62.52 $21,452 - $25,008
400 Added 2.8%
14,688 $916,000
Q2 2021

Aug 13, 2021

BUY
$61.91 - $67.42 $17,582 - $19,147
284 Added 2.03%
14,288 $955,000
Q1 2021

May 13, 2021

BUY
$59.34 - $66.74 $169,534 - $190,676
2,857 Added 25.63%
14,004 $884,000
Q2 2020

Aug 13, 2020

SELL
$54.82 - $64.09 $151,083 - $176,632
-2,756 Reduced 19.82%
11,147 $655,000
Q1 2020

May 12, 2020

BUY
$46.4 - $67.43 $124,073 - $180,307
2,674 Added 23.81%
13,903 $774,000
Q4 2019

Feb 05, 2020

BUY
$49.21 - $64.19 $8,857 - $11,554
180 Added 1.63%
11,229 $721,000
Q3 2019

Nov 13, 2019

BUY
$42.77 - $50.71 $27,843 - $33,012
651 Added 6.26%
11,049 $560,000
Q2 2019

Aug 07, 2019

BUY
$44.62 - $49.34 $15,661 - $17,318
351 Added 3.49%
10,398 $472,000
Q1 2019

May 22, 2019

SELL
$45.12 - $53.8 $82,118 - $97,916
-1,820 Reduced 15.34%
10,047 $479,000
Q4 2018

Feb 14, 2019

SELL
$48.76 - $63.23 $73,920 - $95,856
-1,516 Reduced 11.33%
11,867 $616,000
Q3 2018

Oct 11, 2018

BUY
$55.19 - $62.25 $15,453 - $17,430
280 Added 2.14%
13,383 $831 Million
Q2 2018

Aug 22, 2018

SELL
$50.53 - $62.98 $40,424 - $50,384
-800 Reduced 5.75%
13,103 $725 Million
Q1 2018

May 10, 2018

BUY
$59.92 - $68.98 $833,067 - $959,028
13,903 New
13,903 $879 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $121B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Elmwood Wealth Management, Inc. Portfolio

Follow Elmwood Wealth Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Elmwood Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Elmwood Wealth Management, Inc. with notifications on news.